<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen J</submitter><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1330-1347</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11081830</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>134(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Tetraspanin CD151 is highly expressed in endothelia and reinforces cell adhesion, but its role in vascular inflammation remains largely unknown.&lt;h4>Methods&lt;/h4>In vitro molecular and cellular biological analyses on genetically modified endothelial cells, in vivo vascular biological analyses on genetically engineered mouse models, and in silico systems biology and bioinformatics analyses on CD151-related events.&lt;h4>Results&lt;/h4>Endothelial ablation of &lt;i>Cd151&lt;/i> leads to pulmonary and cardiac inflammation, severe sepsis, and perilous COVID-19, and endothelial CD151 becomes downregulated in inflammation. Mechanistically, CD151 restrains endothelial release of proinflammatory molecules for less leukocyte infiltration. At the subcellular level, CD151 determines the integrit</pubmed_abstract><journal>Circulation research</journal><pubmed_title>CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation.</pubmed_title><pmcid>PMC11081830</pmcid><funding_grant_id>R01 HL132553</funding_grant_id><funding_grant_id>R01 HL133951</funding_grant_id><funding_grant_id>R01 HL172447</funding_grant_id><funding_grant_id>R01 HL148810</funding_grant_id><funding_grant_id>R01 GM135547</funding_grant_id><funding_grant_id>R01 HL137819</funding_grant_id><funding_grant_id>R01 HL164014</funding_grant_id><funding_grant_id>R01 HL162299</funding_grant_id><funding_grant_id>P30 CA225520</funding_grant_id><funding_grant_id>P20 GM103639</funding_grant_id><pubmed_authors>Huang C</pubmed_authors><pubmed_authors>Fung KM</pubmed_authors><pubmed_authors>Sonnenberg A</pubmed_authors><pubmed_authors>Zhang XA</pubmed_authors><pubmed_authors>Wu D</pubmed_authors><pubmed_authors>Papin JF</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Rice HC</pubmed_authors><pubmed_authors>Qu R</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Giles CB</pubmed_authors><pubmed_authors>Stipp CS</pubmed_authors><pubmed_authors>Schiller HB</pubmed_authors><pubmed_authors>Reuter DN</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Walters MS</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Hays FA</pubmed_authors><pubmed_authors>Kanie T</pubmed_authors><pubmed_authors>Wang DW</pubmed_authors><pubmed_authors>Zhao YY</pubmed_authors><pubmed_authors>Subramaniyan B</pubmed_authors><pubmed_authors>Zuo H</pubmed_authors><pubmed_authors>Jiang C</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Mayr CH</pubmed_authors><pubmed_authors>Dai J</pubmed_authors><pubmed_authors>Wren JD</pubmed_authors><pubmed_authors>Georgescu C</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation.</name><description>&lt;h4>Background&lt;/h4>Tetraspanin CD151 is highly expressed in endothelia and reinforces cell adhesion, but its role in vascular inflammation remains largely unknown.&lt;h4>Methods&lt;/h4>In vitro molecular and cellular biological analyses on genetically modified endothelial cells, in vivo vascular biological analyses on genetically engineered mouse models, and in silico systems biology and bioinformatics analyses on CD151-related events.&lt;h4>Results&lt;/h4>Endothelial ablation of &lt;i>Cd151&lt;/i> leads to pulmonary and cardiac inflammation, severe sepsis, and perilous COVID-19, and endothelial CD151 becomes downregulated in inflammation. Mechanistically, CD151 restrains endothelial release of proinflammatory molecules for less leukocyte infiltration. At the subcellular level, CD151 determines the integrit</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-02T12:08:24.809Z</modification><creation>2026-04-18T03:11:00.251Z</creation></dates><accession>S-EPMC11081830</accession><cross_references><pubmed>38557119</pubmed><doi>10.1161/circresaha.123.323190</doi><doi>10.1161/CIRCRESAHA.123.323190</doi></cross_references></HashMap>